Edesa Biotech is trading 6.46% up at $3.79 in after-hours trading on September 29, 2026, with no specific catalyst identified. - The regular-session close was $3.56; recent closes show declines over the prior two sessions. - The company’s news page lists August 19 public offering pricing as its latest release, with no September 29 announcement. - Modest mixed index moves on September 29 do not establish a broader-market explanation for the gain.